Medication info
Shustar 20 mg (Rosuvastatin Calcium)

Shustar 20 mg (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Ankuk Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/box [(10 tablets/Alu-Alu × 3)]
Approval status
Active

MFDS item code 201001005 · Approved 2010.01.28 · Insurance code 650203390

Summary

Main use
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
Who takes it
Adults · Children
Adult dose
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and should continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, the treatment goal, and the patient's response; it may be increased to a maximum of 20 mg per day. 3. Older adults : No dosage adjustment is necessary. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Child dose
Ages 10 to 17 years: The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in the pediatric population.) Under 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
Ankuk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • increased total cholesterol
  • increased LDL-cholesterol
  • elevated Apo-B protein levels
  • dysbetalipoproteinemia
  • coronary heart disease
  • elevated high-sensitivity C-reactive protein
  • hypertension
View approved original text

This medication is used when dietary and exercise control is insufficient for patients with primary hypercholesterolemia and mixed hyperlipidemia. It is also administered as an adjunct to diet for patients with familial hypercholesterolemia, particularly among children over 10 years of age. It lowers total cholesterol and LDL-cholesterol levels, delaying the progression of atherosclerosis, and is also beneficial for patients with primary dysbetalipoproteinemia. Furthermore, in adults with elevated high-sensitivity C-reactive protein levels and cardiovascular risk factors, it is used to reduce the risks of stroke, myocardial infarction, and vascular revascularization. Thus, this drug is effective in improving hypercholesterolemia and various cardiovascular risk conditions.

How to take

Adult dose

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and should continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, the treatment goal, and the patient's response; it may be increased to a maximum of 20 mg per day. 3. Older adults : No dosage adjustment is necessary. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.

Child dose

Ages 10 to 17 years: The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in the pediatric population.) Under 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be used in specific patients. First and foremost, individuals with allergic reactions to this drug should not take it. It should also be avoided in cases of active liver disease or significantly elevated liver enzyme levels. Patients with muscle disorders or those taking cyclosporine, as well as those with severe renal impairment, should not use this medication. Pregnant or nursing women, and women of childbearing age who do not employ appropriate contraception, should not take this drug, and women who may become pregnant should consult a doctor for careful consideration. Additionally, patients at high risk of myopathy or rhabdomyolysis should avoid high doses. Since this drug contains lactose, patients with lactose intolerance or related genetic conditions should refrain from taking it. Caution is advised when administering this drug to patients with liver function problems or those consuming alcohol heavily. Regular liver function tests before and after taking this medication are recommended. Patients with hypercholesterolemia due to hypothyroidism or nephrotic syndrome need to treat the underlying condition first. Muscle pain or myopathy, and rarely severe muscle damage such as rhabdomyolysis may occur, so patients should report any muscle-related symptoms to their doctor immediately. In particular, in the presence of muscle pain, weakness, or cramps, blood tests should be conducted to check for muscle damage and the medication should be discontinued if necessary. It is safest to discontinue this medication in patients with acute severe illness, post-surgical conditions, or severe metabolic disorders. Rarely, this medication can cause severe muscle weakness or ophthalmoplegia; therefore, it should be stopped immediately if such symptoms appear. When used in combination with other medications, the risk of muscle damage may increase, especially when taken with fibrates, so caution is necessary, and high-dose use is prohibited. This drug may have a transient effect on renal function, so periodic renal function tests are advisable when taken in high doses. In Asians, there may be increased systemic exposure to this drug, necessitating a dosage adjustment. In pediatric and adolescent patients, the impact on growth and sexual development is limited, hence care is required. Rare pulmonary diseases such as interstitial lung disease may develop, so if symptoms like dyspnea or persistent cough arise, consult a doctor immediately. If severe liver damage symptoms or jaundice occur during treatment, discontinue the drug immediately. The risk of diabetes may increase, but because the cardiovascular benefits outweigh this, do not discontinue and maintain strict blood glucose control. The drug response and side effect risk may differ based on genetic factors, so dosage adjustments may be necessary if needed. Severe skin reactions may occur, so if symptoms like skin rash, itching, or fever appear, discontinue the drug immediately and consult a doctor. There is no specific antidote for overdose, so symptomatic treatment and monitoring of liver function and muscle enzyme levels may be necessary. This drug does not significantly impact driving or operating machinery; however, caution should be taken due to potential dizziness. Pregnant or nursing women should not use this drug, and women planning a pregnancy must ensure adequate contraception.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptom drug reaction syndrome, drug rash resembling psoriasis, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, joint pain, fatigue, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal distension, abnormal liver function tests, syncope, widespread pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight container to protect it from air and moisture, and it is advisable to keep it in a cool place below 30 degrees Celsius. Storing it this way helps maintain its effectiveness and prevents degradation.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu × 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.